Rethinking vaccine hesitancy among minority groups

In countries such as the UK and the USA that are privileged to   have   adequate   supplies   of   COVID-19   vaccines   but   are   also   plagued   by   histories   of   deep   inequities   and   white  supremacy,  it  was  predictable  that  the  benefits  of  COVID-19 vaccines would not be equally shared across all sectors of society. The challenge of low vaccine access and uptake by  some  groups  is  multidimensional.  Although  vaccine    hesitancy    is    often    implicated,    this    framing    mistakenly places the responsibility on minoritised groups to  become  less  hesitant,  rather  than  on  public  health  systems to become more trustworthy and accessible. This framing  also  inadvertently  underemphasises  barriers  to  vaccine access that have been incompletely addressed for these populations.